Caxton Associates (New York)’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$394K Sell
3,123
-13,882
-82% -$2.06M 0.01% 371
2024
Q3
$2.83M Buy
+17,005
New +$2.57M 0.11% 74

Other funds holding THC

Caxton Associates (New York)'s THC Position: Q4 2024 in Review

Caxton Associates (New York) reduced its Tenet Healthcare (THC) stake by 82% in Q4 2024, selling an estimated $2.06M and leaving 3,123 shares worth $394K. The position accounts for 0.01% of the portfolio, ranked #371.

Caxton Associates (New York) first reported a position in THC in Q3 2024 and has held it in 2 quarters since. The position peaked at $2.83M in Q3 2024. 577 funds tracked by Wall St. Rank hold THC as of Q4 2024.

  • Caxton Associates (New York) held 3,123 shares of Tenet Healthcare worth $394K as of Q4 2024.
  • Caxton Associates (New York) sold 13,882 Tenet Healthcare shares in Q4 2024, an estimated $2.06M.
  • Tenet Healthcare made up 0.01% of Caxton Associates (New York)'s portfolio in Q4 2024, its #371 holding.
  • Caxton Associates (New York) first reported a position in Tenet Healthcare in Q3 2024 and has held it in 2 quarters since.
  • Caxton Associates (New York)'s Tenet Healthcare position peaked at $2.83M in Q3 2024.
  • 577 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.